DelveInsight’s “Homozygous Familial Hypercholesterolemia Market” report provides a thorough comprehension of the Homozygous Familial Hypercholesterolemia historical and forecasted epidemiology, and the Homozygous Familial Hypercholesterolemia market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The HoFH market report also proffers an analysis of the current HoFH treatment algorithm/practice, market drivers, market barriers, and unmet medical needs.
Some of the imperative takeaways from the Homozygous Familial Hypercholesterolemia Market Research Report:
For further information on Market Impact by Therapies, visit: Homozygous Familial Hypercholesterolemia Drugs Market Analysis
Homozygous Familial Hypercholesterolemia Companies are:
Homozygous Familial Hypercholesterolaemia (HoFH) is a rare and life-threatening disease characterized initially clinically by plasma cholesterol levels >13 mmol/L, extensive xanthomas, and marked premature and progressive atherosclerotic cardiovascular disease (ACVD). It is a more severe form of Familial Hypercholesterolemia (FH), an autosomal dominant genetic disorder.
As per DelveInsight’s analysis, the total HoFH prevalence in the 7MM was estimated at around 3,882 cases in 2020. It was also observed that HoFH affects males and females equally.
Get a complete epidemiological segmentation @ Homozygous Familial Hypercholesterolemia Epidemiological Analysis
Scope of the Homozygous Familial Hypercholesterolemia Market Insight Report
Request for a Webex demo of the report @ Homozygous Familial Hypercholesterolemia Therapeutics Market
Table of Contents
1
Homozygous Familial Hypercholesterolemia (HoFH) Key Insights
2
Homozygous Familial Hypercholesterolemia Executive Summary
3
Homozygous Familial Hypercholesterolemia Market Overview at a Glance
4
Homozygous Familial Hypercholesterolemia Disease Background And Overview
5
Recognized Establishments
6
Homozygous Familial Hypercholesterolemia Treatment And Management
7
HoFH Guidelines By European Atherosclerosis Society (EAS) (2014)
8
Japan Atherosclerosis Society (JAS) Guidelines For Prevention of Atherosclerotic Cardiovascular Diseases 2017
9
Guidance For Pediatric Familial Hypercholesterolemia (2017)
10
HoFH Treatment Algorithm
11
Homozygous Familial Hypercholesterolemia Epidemiology And Patient Population
11.1
The United States
11.2
EU5 Countries
11.2.1
Germany
11.2.2
France
11.2.3
Italy
11.2.4
Spain
11.2.5
The United Kingdom
11.3
Japan
12
Unmet Needs
13
HoFH Marketed Drugs
13.1
Repatha (Evolocumab/Amg 145): Amgen
13.2
Juxtapid (Lomitapide): Aegerion Pharmaceutical
13.3
Evkeeza (Evinacumab): Regeneron Pharmaceuticals
13.4
Praluent (Alirocumab): Sanofi/Regeneron Pharmaceuticals
14
Homozygous Familial Hypercholesterolemia Emerging Drugs
14.1
Inclisiran: Alnylam Pharmaceuticals/Novartis
14.2
Lib003: Lib Therapeutics
14.3
Gemcabene: Neurobo Pharmaceuticals
14.4
Aro-Ang3: Arrowhead Pharmaceuticals
15
HoFH Market Access And Reimbursement
16
7MM Homozygous Familial Hypercholesterolemia Market Analysis
16.1
The United States Homozygous Familial Hypercholesterolemia Market Size
16.2
EU-5 Homozygous Familial Hypercholesterolemia Market Size
16.2.1
Germany Market Size
16.2.2
France Market Size
16.2.3
Italy Market Size
16.2.4
Spain Market Size
16.2.5
The United Kingdom Market Size
16.3
Japan Homozygous Familial Hypercholesterolemia Market Size
17
Case Reports of HoFH
18
Homozygous Familial Hypercholesterolemia Market Drivers
19
Homozygous Familial Hypercholesterolemia Market Barriers
20
SWOT Analysis Of Homozygous Familial Hypercholesterolemia
21
Appendix
22
DelveInsight Capabilities
23
Disclaimer
24
About DelveInsight
Browse full report with detailed TOC with charts, figures, tables @ https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market